|
Up a level |
Caniglia, Ellen C; Phillips, Andrew; Porter, Kholoud; Sabin, Caroline A; Winston, Alan; Logan, Roger; Gill, John; Vandenhende, Marie-Anne; Barger, Diana; Lodi, Sara; Moreno, Santiago; Arribas, José Ramón; Pacheco, Antonio; Cardoso, Sandra W; Chrysos, George; Gogos, Charalabos; Abgrall, Sophie; Costagliola, Dominique; Meyer, Laurence; Seng, Remonie; van Sighem, Ard; Reiss, Peter; Muga, Roberto; Hoyos, Santiago Pérez; Braun, Dominique; Hauser, Christoph; Barrufet, Pilar; Leyes, Maria; Tate, Janet; Justice, Amy; Hernán, Miguel A (2018). Commonly prescribed antiretroviral therapy regimens and incidence of AIDS-defining neurological conditions. Journal of Acquired Immune Deficiency Syndromes, 77(1):102-109.
Cain, Lauren E; Caniglia, Ellen C; Phillips, Andrew; Olson, Ashley; Muga, Roberto; Pérez-Hoyos, Santiago; Abgrall, Sophie; Costagliola, Dominique; Rubio, Rafael; Jarrín, Inma; Bucher, Heiner; Fehr, Jan; van Sighem, Ard; Reiss, Peter; Dabis, François; Vandenhende, Marie-Anne; Logan, Roger; Robins, James; Sterne, Jonathan A C; Justice, Amy; Tate, Janet; Touloumi, Giota; Paparizos, Vasilis; Esteve, Anna; Casabona, Jordi; Seng, Rémonie; Meyer, Laurence; Jose, Sophie; Sabin, Caroline; Hernán, Miguel A; et al (2016). Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals. Medicine, 95(41):e5133.